1921
Volume 75, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

The prevalence and risk factors for hepatitis delta virus (HDV) infection among Mongolian school children were assessed by detecting the antibody against HDV and HDV RNA, and through structured interviews. The study subjects consisted of 181 children with the past or ongoing hepatitis B virus infection who were investigated during the nationwide serosurvey conducted in 2004. The prevalence of antibody to HDV was 6.1%, with the proportion of 13.6% among hepatitis B surface antigen (HBsAg)-positive subjects, all of whom had HDV RNA. Multivariate logistic regression analyses showed that injections (> 11 times) (odds ratio [OR] = 8.31, 95% confidence interval [CI] = 1.28–54.07) and blood sampling (> 3 times) (OR = 5.34, 95% CI = 1.12–25.53) in health care settings, hospitalization (> 3 times) (OR = 6.20, 95% CI = 1.18–32.71), and cohabitating with patients with chronic hepatitis (OR = 4.57, 95% CI = 1.26–16.55) predicted the seropositivity for antibody to HDV. These results suggest that parenteral exposures in health care settings and household transmission are the main routes of HDV transmission among Mongolian children.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2006.75.365
2006-08-01
2017-11-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/75/2/0750365.html?itemId=/content/journals/10.4269/ajtmh.2006.75.365&mimeType=html&fmt=ahah

References

  1. Rizzetto M, Hoyer B, Canese MG, Shih JWK, Purcell RH, Gerin JL, 1980. Delta agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A 77 : 6124–6128.
  2. Lai MM, 1995. The molecular biology of hepatitis delta virus. Annu Rev Biochem 64 : 259–286.
  3. Huo TI, Wu JC, Wu SI, Chang AL, Lin SK, Pan CH, Huang YH, Chang FY, Lee SD, 2003. Changing seroepidemiology of hepatitis B, C, and D virus infections in high-risk populations. J Med Virol 72 : 41–45.
  4. Purcell RH, 1994. Hepatitis viruses: changing patterns of human disease. Proc Natl Acad Sci U S A 91 : 2401–2406.
  5. Rizzetto M, Ponzetto A, Forzani I, 1991. Epidemiology of hepatitis delta virus: overview. Prog Clin Biol Res 364 : 1–20.
  6. International Agency for Research on Cancer, 1994. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Hepatitis Viruses. Volume 59: 223–253.
  7. Farci P, 2003. Delta hepatitis: an update. J Hepatol 39 : S212–S219.
  8. Gerin JL, Casey JL, Purcell RH, 2001. Hepatitis delta virus. Knipe DM, Howley PM, eds. Fields Virology. Fourth edition. Philadelphia: Lippincott Williams and Wilkins, 2819–2829.
  9. Valla D, 2003. EASL international consensus conference on hepatitis B. J Hepatol 38 : 533–540.
  10. Hadziyannis SJ, 1997. Review: hepatitis delta. J Gastroenterol Hepatol 12 : 289–298.
  11. Abe K, Hayakawa E, Sminov AV, Rossina AL, Ding X, Huy TT, Sata T, Uchaikin VF, 2004. Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia. J Clin Virol 30 : 57–61.
  12. Nymadava P, Anan’ev VA, Oiuunbileg Zh, Chernovetskii MA, 1988. The frequency of detecting antibodies to the delta antigen in virtually healthy HBsAg and anti-HBs carriers in Ulan-Bator. Vopr Virusol 33 : 246–247.
  13. Oyunsuren T, 2000. Viral hepatitis in Mongolia. Minophagen Med Rev 45 : 140–147.
  14. Inoue J, Takahashi M, Nishizawa T, Narantuya L, Sakuma M, Kagawa Y, Shimosegawa T, Okamoto H, 2005. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia. J Med Virol 76 : 333–340.
  15. Takahashi M, Nishizawa T, Gotanda Y, Tsuda F, Komatsu F, Kawabata T, Hasegawa K, Altankhuu M, Chimedregzen U, Narantuya L, Hoshino H, Hino K, Kagawa Y, Okamoto H, 2004. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia. Clin Diagn Lab Immunol 11 : 392–398.
  16. Davaalkham D, Ojima T, Nymadawa P, Uehara R, Watanabe M, Oki I, Nakamura Y, 2006. Prevalence and risk factors for hepatitis C virus infection in Mongolian children: findings from a nationwide survey. J Med Virol 78 : 466–472.
  17. Davaalkham D, Ojima T, Nymadawa P, Tsend N, Lkhagvasuren TS, Wiersma S, Uehara R, Watanabe M, Oki I, Nakamura Y, 2007. Seroepidemiology of hepatitis B virus infection in Mongolian children: a nationwide survey. Pediatr Int 49: (in press).
  18. Ebright JR, Altantsetseg T, Oyungerel R, 2003. Emerging infectious diseases in Mongolia. Emerg Infect Dis 9 : 1509–1515.
  19. Edstam JS, Dulmaa N, Nymadawa P, Rinchin A, Khulan J, Kimball AM, 2002. Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds. Prev Med 34 : 207–214.
  20. Heller T, Hoofnagle JH, 2003. Denying the wolf access to sheep’s clothing. J Clin Invest 112 : 319–321.
  21. Taylor JM, 2006. Hepatitis delta virus. Virology 344 : 71–76.
  22. Huo TI, Wu JC, Lin RY, Sheng WY, Chang FY, Lee SD, 1997. Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol 12 : 747–751.
  23. Kao JH, Chen PJ, Lai MY, Chen DS, 2002. Hepatitis D virus genotypes in intravenous drug users in Taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J Clin Microbiol 40 : 3047–3049.
  24. Sagnelli E, Stroffolini T, Ascione A, Chiaramonte M, Craxi A, Giusti G, Piccinino F, 1997. Decrease in HDV endemicity in Italy. J Hepatol 26 : 20–24.
  25. Hadziyannis SJ, Dourakis SP, Papaioannou C, Alexopoulou A, Hadziyannis ES, Gioustozi A, 1993. Changing epidemiology and spreading modalities of hepatitis delta virus infection in Greece. Prog Clin Biol Res 382 : 259–266.
  26. Navascues CA, Rodriguez M, Sotorrio NG, Sala P, Linares A, Suarez A, Rodrigo L, 1995. Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol 90 : 1981–1984.
  27. Sagnelli E, Felaco FM, Filippini P, Scolastico C, Rapicetta M, Stroffolini T, Piccinino F, 1997. Multiple hepatitis virus infections in chronic HBsAg carriers in Naples. Arch Virol 142 : 445–451.
  28. Craxi A, Tine F, Vinci M, Almasio P, Camma C, Garofalo G, Pagliaro L, 1991. Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk. Am J Epidemiol 134 : 641–650.
  29. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, Sagnelli E, Brunetto MR, Rizzetto M, 2000. Chronic hepatitis D: A vanishing disease? An Italian multi-center study. Hepatology 32 : 824–827.
  30. Niro GA, Casey JL, Gravinese E, Garrubba M, Conoscitore P, Sagnelli E, Durazzo M, Caporaso N, Perri F, Leandro G, Facciorusso D, Rizzetto M, Andriulli A, 1999. Intrafamilial transmission of hepatitis delta virus: molecular evidence. J Hepatol 30 : 564–569.
  31. Liaw YF, Tsai SL, Sheen IS, Chao M, Yeh CT, Hsieh SY, Chu CM, 1998. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers. Am J Gastroenterol 93 : 354–359.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2006.75.365
Loading
/content/journals/10.4269/ajtmh.2006.75.365
Loading

Data & Media loading...

  • Received : 26 Jan 2006
  • Accepted : 28 Mar 2006

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error